Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).
We are currently recruiting people with Autosomal Dominant Polycystic Kidney Disease (ADPKD) for the PREVENT-ADPKD trial. The aim of the trial is to determine if prescribed fluid intake slows the growth of kidney cysts in ADPKD.
We very much appreciate your help and support with this study. Your participation will be invaluable in helping find a treatment for Polycystic Kidney Disease. Please do not hesitate to contact the trial coordinator should you have any questions.
This study has received ethics approval from the Western Sydney Local Health District Human Research Ethics Committee (Reference No. 4129: AU RED HREC/14/WMEAD/414)
To be eligible to participate patients must meet the following criteria:
If you are interested in assisting with this important and exciting area of research, please contact the study facilitator: